This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Search Results
Search
Filter by
Content Type
Client
Focus Area
Capability
Topic
-
Wilhelmina Ross
Senior Research Associate
-
Mary Mesnard
Principal Research Associate
-
RSV Vaccine Protects Older Adults from Serious Illness
October 21, 2024
A study providing some of the first real-world data on RSV effectiveness shows that adults aged 60 years and older who received RSV vaccination were…
-
Ann Truelove
Senior Research Associate
-
How can we monitor and learn trends about Lyme disease?
Using a data coordinating center for Lyme disease surveillance
-
Westat-Led Article Awarded 2023 JRM Best Paper
April 30, 2024
The Journal of Registry Management (JRM) Best Paper of the Year for 2023 has been awarded to a Westat-led journal article. “Rationale and Methodologic Approach…
-
COVID Vaccines Cut Hospital Risk for Immunocompromised Adults
April 4, 2024
From September 2023 to February 2024, adults with weakened immune systems who had received an updated COVID-19 vaccine were about 1/3 less likely to be…
-
The Westat Team Behind VISION’s Success
April 1, 2024
The VISION Vaccine Effectiveness Network, launched by the Centers for Disease Control and Prevention (CDC) in 2020, spurred a monumental shift in vaccine assessment, guiding…
-
Latest Data on Flu and COVID-19 Vaccine Effectiveness
March 1, 2024
Interim effectiveness estimates of the 2023-24 influenza and COVID-19 vaccines are now available in 2 VISION 2.0 Network papers, which have been published in the…
-
Mesnard Honored as an NCRA 50-for-50 Hero
February 14, 2024
Mary Mesnard, a Westat Principal Research Associate, has been designated by the National Cancer Registrars Association (NCRA) as an NCRA 50-for-50 Hero. The 50-for-50 Recognition…